Suppr超能文献

微小RNA机制的组成部分——Dicer在前列腺腺癌中的上调。

Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma.

作者信息

Chiosea Simion, Jelezcova Elena, Chandran Uma, Acquafondata Marie, McHale Teresa, Sobol Robert W, Dhir Rajiv

机构信息

Department of Pathology, University of Pittsburgh, University of Pittsburgh Medical Center Presbyterian, C920.1, 200 Lothrop St., Pittsburgh, PA 15213, USA.

出版信息

Am J Pathol. 2006 Nov;169(5):1812-20. doi: 10.2353/ajpath.2006.060480.

Abstract

MicroRNAs are small noncoding 18- to 24-nt RNAs that are predicted to regulate expression of as many as 30% of protein-encoding genes. In prostate adenocarcinoma, 39 microRNAs are up-regulated, and six microRNAs are down-regulated. Production and function of microRNA requires coordinated processing by proteins of the microRNA machinery. Dicer, an RNase III endonuclease, is an essential component of the microRNA machinery. From a gene array analysis of 16 normal prostate tissue samples, 64 organ-confined, and four metastatic prostate adenocarcinomas, we identified an up-regulation of major components of the microRNA machinery, including Dicer, in metastatic prostate adenocarcinoma. Immunohistochemical studies on a tissue microarray consisting of 232 prostate specimens confirmed up-regulation of Dicer in prostatic intraepithelial neoplasia and in 81% of prostate adenocarcinoma. The increased Dicer level in prostate adenocarcinoma correlated with clinical stage, lymph node status, and Gleason score. Western blot analysis of benign and neoplastic prostate cell lines further confirmed Dicer up-regulation in prostate adenocarcinoma. Dicer up-regulation may explain an almost global increase of microRNA expression in prostate adenocarcinoma. The presence of up-regulated microRNA machinery may predict the susceptibility of prostate adenocarcinoma to RNA interference-based therapy.

摘要

微小RNA是一类长度为18至24个核苷酸的小型非编码RNA,据预测可调控多达30%的蛋白质编码基因的表达。在前列腺腺癌中,有39种微小RNA上调,6种微小RNA下调。微小RNA的产生和功能需要微小RNA机制中的蛋白质协同加工。Dicer是一种核糖核酸酶III内切核酸酶,是微小RNA机制的重要组成部分。通过对16个正常前列腺组织样本、64个器官局限性前列腺腺癌样本和4个转移性前列腺腺癌样本进行基因芯片分析,我们发现在转移性前列腺腺癌中,微小RNA机制的主要成分(包括Dicer)上调。对由232个前列腺标本组成的组织芯片进行免疫组织化学研究证实,在前列腺上皮内瘤变和81%的前列腺腺癌中Dicer上调。前列腺腺癌中Dicer水平的升高与临床分期、淋巴结状态和 Gleason评分相关。对良性和肿瘤性前列腺细胞系进行蛋白质印迹分析进一步证实前列腺腺癌中Dicer上调。Dicer上调可能解释了前列腺腺癌中微小RNA表达几乎整体增加的现象。上调的微小RNA机制的存在可能预示前列腺腺癌对基于RNA干扰的治疗的敏感性。

相似文献

4
Down-regulation of dicer expression in ovarian cancer tissues.卵巢癌组织中 dicer 表达下调。
Clin Biochem. 2010 Feb;43(3):324-7. doi: 10.1016/j.clinbiochem.2009.09.014. Epub 2009 Sep 25.
7
Overexpression of Dicer predicts poor survival in colorectal cancer.Dicer 过表达预示结直肠癌患者预后不良。
Eur J Cancer. 2011 Jun;47(9):1414-9. doi: 10.1016/j.ejca.2011.01.006. Epub 2011 Feb 21.

引用本文的文献

6
7
ADAR1-Mediated RNA Editing and Its Role in Cancer.ADAR1介导的RNA编辑及其在癌症中的作用。
Front Cell Dev Biol. 2022 Jul 11;10:956649. doi: 10.3389/fcell.2022.956649. eCollection 2022.

本文引用的文献

1
Partners in dicing.切割伙伴。
Genome Biol. 2006;7(3):210. doi: 10.1186/gb-2006-7-3-210. Epub 2006 Mar 31.
5
The role of PACT in the RNA silencing pathway.PACT在RNA沉默途径中的作用。
EMBO J. 2006 Feb 8;25(3):522-32. doi: 10.1038/sj.emboj.7600942. Epub 2006 Jan 19.
6
MicroRNAs as oncogenes.作为致癌基因的微小RNA
Curr Opin Genet Dev. 2006 Feb;16(1):4-9. doi: 10.1016/j.gde.2005.12.005. Epub 2005 Dec 19.
9
Identification of novel argonaute-associated proteins.新型AGO相关蛋白的鉴定。
Curr Biol. 2005 Dec 6;15(23):2149-55. doi: 10.1016/j.cub.2005.10.048. Epub 2005 Nov 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验